Meeting
2013 ASCO Annual Meeting
A comparative analysis of distant recurrence risk assessments by Oncotype DX recurrence score alone and integrated with clinicopathologic factors in early-stage breast cancer.
Authors
Ciara Marie Kelly
Department of Medical Oncology, Cork University Hospital, Cork, Ireland
Ciara Marie Kelly , Rose Beamish , John McCaffrey , Martina SMITH , John Crown , Miriam O'Connor , Sharon F. McGee , Seamus O'Reilly , Eugene J. Moylan , Ana M. Gonzalez-Angulo , Jennifer Keating Litton , Lajos Pusztai , Catherine Margaret Kelly
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 31, 2013 (suppl; abstr 598)
DOI
10.1200/jco.2013.31.15_suppl.598
Abstract #
598
Poster Bd #
8E
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Prediction of early and late distant recurrence in early-stage breast cancer with Breast Cancer Index.
First Author: Yi Zhang
Poster
2019 ASCO Annual Meeting
A novel 95-gene signature (Curebest 95GC Breast) that predicts recurrence-risk in patients with ER-positive, HER2-negative, node-negative, early-stage primary invasive breast cancer with an intermediate Oncotype DX Recurrence Score.
First Author: Takeo Fujii
Poster
2018 ASCO Annual Meeting
Residual risk assessment with the Breast Cancer Index (BCI) for prediction of late distant recurrence (DR) in patients from the TransATAC study.
First Author: Ivana Sestak
